The Peptide Report
Silicon Valley operators are quietly moving past melatonin in search of deeper, cleaner sleep. Here's why delta sleep-inducing peptide—delivered intranasally—has become the executive performance community's quiet favorite in 2026.
Inside the quiet sleep optimization shift happening among founders, VCs, and executive performers in 2026 — and why DSIP nasal spray has become the category-defining alternative to melatonin.
A quiet shift is happening in the upper ranks of Silicon Valley: high-performing executives are trading traditional sleep aids for doctor-formulated nasal sprays. Here's the science behind the trend.
A growing cohort of Silicon Valley founders and operators are quietly retiring melatonin in favor of delta-sleep-inducing peptide nasal sprays. Here's the science behind the shift — and why next-day cognition is the new sleep metric.
A new category of intranasal wellness sprays is quietly reshaping how high-performers wind down at night. Inside the rise of DSIP nasal sprays among executives who refuse to trade tomorrow for tonight.
A new generation of high-performance operators is abandoning melatonin for something more precise. Inside the quiet rise of DSIP nasal spray and the science of sleep architecture optimization.
